NO942781L - Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger - Google Patents

Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger

Info

Publication number
NO942781L
NO942781L NO942781A NO942781A NO942781L NO 942781 L NO942781 L NO 942781L NO 942781 A NO942781 A NO 942781A NO 942781 A NO942781 A NO 942781A NO 942781 L NO942781 L NO 942781L
Authority
NO
Norway
Prior art keywords
inactivating viral
bacterial blood
blood contaminants
inactivating
viral
Prior art date
Application number
NO942781A
Other languages
English (en)
Other versions
NO942781D0 (no
Inventor
Jr Raymond P Goodrich
Nagendar Yerram
Roger W Hackett
Marjan Van Borssum Waalkes
Original Assignee
Cryopharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryopharm Corp filed Critical Cryopharm Corp
Publication of NO942781D0 publication Critical patent/NO942781D0/no
Publication of NO942781L publication Critical patent/NO942781L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

En fremgangsmåte for inaktivering av virale og/eller bakteriell kontaminasjon i blodcelleprodukter, så som erythrocyter og blodplater, eller proteinfraksjoner, er beskrevet. Cellene eller proteinfraksjonene blir blandet med kjemiske sensibiliserende midler og bestrålt med for eksempel gamma- eller røntgenbe-strålning.
NO942781A 1992-01-27 1994-07-26 Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger NO942781L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82569192A 1992-01-27 1992-01-27
PCT/US1993/000401 WO1993014791A2 (en) 1992-01-27 1993-01-27 Method of inactivation of viral and bacterial blood contaminants

Publications (2)

Publication Number Publication Date
NO942781D0 NO942781D0 (no) 1994-07-26
NO942781L true NO942781L (no) 1994-09-15

Family

ID=25244689

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942781A NO942781L (no) 1992-01-27 1994-07-26 Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger

Country Status (10)

Country Link
EP (1) EP0633786B1 (no)
JP (1) JP2001509773A (no)
AT (1) ATE203679T1 (no)
AU (1) AU3476593A (no)
CA (1) CA2128866A1 (no)
DE (1) DE69330514T2 (no)
IL (1) IL104530A0 (no)
NO (1) NO942781L (no)
WO (1) WO1993014791A2 (no)
ZA (1) ZA93587B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
US5578486A (en) * 1994-08-05 1996-11-26 International Tlb Research Institute, Inc. Recombinant microbial fertilizer and methods for its production
WO1996008965A1 (en) * 1994-09-22 1996-03-28 Baxter International, Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
BR9608776A (pt) * 1995-05-19 2000-10-24 New York Blood Ct Inc Processo de uso de ftalocianinas para inativar parasitas do sangue
JP2000510101A (ja) * 1996-03-29 2000-08-08 セラコス・インコーポレーテツド 白血球のフォトフェレーシス処置
CA2251624C (en) 1996-04-09 2010-06-08 Therakos, Inc. Method for removal of psoralens from biological fluids
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
CA2285935C (en) 1997-04-08 2011-01-18 Baxter Aktiengesellschaft An immunotolerant prothrombin complex preparation
ES2265664T3 (es) * 1997-07-10 2007-02-16 Therakos, Inc. Tratamiento de enfermedades inflamatorias del intestino o de la vejiga urinaria.
DE69826521T2 (de) * 1998-01-06 2005-09-29 Cerus Corp., Concord Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
WO2014194931A1 (en) 2013-06-03 2014-12-11 Onderzoeks- En Ontwikkelingsfonds Rode Kruis-Vlaanderen Pathogen reduction treatment
EP3172222A4 (en) 2014-07-24 2018-03-21 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
WO2018148595A1 (en) 2017-02-10 2018-08-16 Washington University Antibodies to tip1 and methods of use thereof
WO2021074970A1 (ja) * 2019-10-15 2021-04-22 株式会社日立ハイテク 核酸試料処理装置および核酸試料処理方法
MX2023014233A (es) * 2021-06-14 2024-01-25 St Andrews Pharmaceutical Tech Limited Aparato para mejorar la hidratación y/o reducir el tamaño de partícula de un producto y un método de uso del mismo.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
SU959786A1 (ru) * 1980-04-17 1982-09-23 Московский технологический институт мясной и молочной промышленности Способ консервировани цельной крови
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
EP0124363B1 (en) * 1983-05-02 1990-12-19 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
WO1991016060A1 (en) * 1990-04-16 1991-10-31 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
CA2089005C (en) * 1991-06-21 1999-01-19 John Chapman Method for inactivating pathogens in a body fluid

Also Published As

Publication number Publication date
AU3476593A (en) 1993-09-01
EP0633786B1 (en) 2001-08-01
JP2001509773A (ja) 2001-07-24
CA2128866A1 (en) 1993-08-05
WO1993014791A3 (en) 2000-02-17
WO1993014791A2 (en) 1993-08-05
EP0633786A1 (en) 1995-01-18
IL104530A0 (en) 1993-05-13
EP0633786A4 (en) 1995-04-19
DE69330514D1 (de) 2001-09-06
NO942781D0 (no) 1994-07-26
ATE203679T1 (de) 2001-08-15
DE69330514T2 (de) 2002-03-28
ZA93587B (en) 1994-07-07

Similar Documents

Publication Publication Date Title
NO942781D0 (no) Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger
EP0483304A4 (en) Method of inactivation of viral and bacterial blood contaminants
IT1195071B (it) Apparecchio e procedimento per analizzare la finitura di articoli trasparenti,in particolare contenitori di vetro
NO913013D0 (no) Fremgangsmaate for kjemisk behandling av slam og vaesker.
ATE80803T1 (de) Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl.
ATE71095T1 (de) Azolylmethyloxirane - ihre herstellung und verwendung als pflanzenschutzmittel.
FI960281A (fi) Menetelmä tuotteiden sterilisoimiseksi
AU3363689A (en) Blood processing apparatus
DE69314462D1 (de) Abdichtbarer behälter zum konservieren und behandeln analytischer proben
DK545786A (da) Hidtil ukendte insulinderivater og farmaceutiske praeparater, som indeholder disse derivater
IT8122595A0 (it) Procedimento per il trattamento di lisato di limulo e reagente contenente il lisato trattato.
ATE176326T1 (de) Gelkassette für eine verbesserte elektroforetische trennung und verfahren zu deren herstellung
DE3670294D1 (de) Monoklonale antikoerper gegen kernproteine von lymphadenopathie-assoziierten viren.
CA2056619A1 (en) Method of inactivation of viral and bacterial blood contaminants
FI854395A (fi) Sv40-expressionsvektor innehaollande hbxag-antigen som expressionsmarkering.
DK159114C (da) Benzyldihydrofuropyridinderivater og praeparater indeholdende disse forbindelser
ATE65918T1 (de) Verfahren zur markierung von substanzen mit technetium oder rhenium.
ATE170709T1 (de) Verwendung von l-carnitin und alkanoyl l- carnitine zum bewahren von transfusionsblut, und sie enthaltenden stabilisierungslösungen
NO874940L (no) Fremgangsmaate og innretning for oppredning av blandet avfall, som husholdningssoeppel eller fraksjoner derav, for gjenvinning av plastfoliematerialer.
ATE329603T1 (de) Implantat mit immunisolierten stromazellen und deren verwendung
DE3677092D1 (de) Emulsionen zur entseuchung giftiger, chemischer mittel, deren herstellung und verwendung.
DE3776170D1 (de) Quelle ultravioletter strahlen und verwendung derselben in verfahren mit photochemischer reaktion.
IT7924779A0 (it) Impianto per la sterilizzazione di liquidi in genere mediante radiazioni ultraviolette e relativo procedimento.
DE3585049D1 (de) Monoklonale antikoerper.
DK560889A (da) Lysozymgen fra streptomycesarter, deri indgaaende oligonukleotidsonde samt hybridvektor og mikroorganismer indeholdende det